Back to today’s briefing

Story perspectives

Revolutionary Technique Streamlines Gene Therapy Production Process

5/14/2025

43 7

Summary

Story summary

Gene therapy is making strides with FDA-approved treatments, yet the production of recombinant adeno-associated viruses (rAAVs) remains a hurdle. A groundbreaking study from the University of Osaka unveils mass photometry, a technique that effortlessly identifies full and empty rAAVs. This advancement promises to simplify production, cut costs, and elevate quality control in the field of gene therapy.

1 of 1

Story summary

Gene therapy is making strides with FDA-approved treatments, yet the production of recombinant adeno-associated viruses (rAAVs) remains a hurdle. A groundbreaking study from the University of Osaka unveils mass photometry, a technique that effortlessly identifies full and empty rAAVs. This advancement promises to simplify production, cut costs, and elevate quality control in the field of gene therapy.